Mylan NV (MYL) Stake Raised by Regent Investment Management LLC

Share on StockTwits

Regent Investment Management LLC lifted its stake in shares of Mylan NV (NASDAQ:MYL) by 14.1% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 87,730 shares of the company’s stock after purchasing an additional 10,825 shares during the period. Mylan makes up about 1.0% of Regent Investment Management LLC’s holdings, making the stock its 26th biggest position. Regent Investment Management LLC’s holdings in Mylan were worth $3,211,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in the company. James Investment Research Inc. raised its position in Mylan by 9.5% during the second quarter. James Investment Research Inc. now owns 16,915 shares of the company’s stock valued at $611,000 after buying an additional 1,470 shares during the period. Sumitomo Life Insurance Co. raised its position in Mylan by 4.1% during the second quarter. Sumitomo Life Insurance Co. now owns 42,775 shares of the company’s stock valued at $1,546,000 after buying an additional 1,679 shares during the period. Alerus Financial NA raised its position in Mylan by 1.6% during the second quarter. Alerus Financial NA now owns 111,011 shares of the company’s stock valued at $4,011,000 after buying an additional 1,697 shares during the period. Whittier Trust Co. of Nevada Inc. raised its position in Mylan by 8.5% during the second quarter. Whittier Trust Co. of Nevada Inc. now owns 21,998 shares of the company’s stock valued at $794,000 after buying an additional 1,726 shares during the period. Finally, GAM Holding AG raised its position in Mylan by 30.9% during the second quarter. GAM Holding AG now owns 8,070 shares of the company’s stock valued at $292,000 after buying an additional 1,907 shares during the period. 82.91% of the stock is currently owned by institutional investors.

NASDAQ MYL traded down $0.54 on Monday, reaching $31.67. The stock had a trading volume of 451,926 shares, compared to its average volume of 5,386,523. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.29 and a quick ratio of 0.77. Mylan NV has a 1 year low of $31.54 and a 1 year high of $47.82. The company has a market capitalization of $16.61 billion, a P/E ratio of 6.94, a price-to-earnings-growth ratio of 1.03 and a beta of 1.43.

Mylan (NASDAQ:MYL) last issued its earnings results on Wednesday, August 8th. The company reported $1.07 EPS for the quarter, missing analysts’ consensus estimates of $1.22 by ($0.15). Mylan had a net margin of 3.90% and a return on equity of 18.48%. The firm had revenue of $2.81 billion during the quarter, compared to analysts’ expectations of $2.95 billion. During the same quarter last year, the firm earned $1.10 EPS. The business’s revenue for the quarter was down 5.2% compared to the same quarter last year. On average, equities analysts anticipate that Mylan NV will post 4.64 EPS for the current year.

Several research firms recently weighed in on MYL. Zacks Investment Research raised Mylan from a “strong sell” rating to a “hold” rating in a research report on Tuesday, October 9th. Morgan Stanley lowered Mylan from an “overweight” rating to an “equal weight” rating and dropped their price target for the company from $46.00 to $36.00 in a research report on Tuesday, October 9th. BidaskClub lowered Mylan from a “sell” rating to a “strong sell” rating in a research report on Tuesday, October 9th. Mizuho lowered Mylan from a “buy” rating to a “neutral” rating in a research report on Friday, October 5th. Finally, ValuEngine lowered Mylan from a “sell” rating to a “strong sell” rating in a research report on Thursday, October 4th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and eleven have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $47.73.

Mylan Profile

Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, brand name, and over-the-counter (OTC) products worldwide. The company operates through three segments: North America, Europe, and Rest of World. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.

See Also: What are the economic characteristics of a bear market?

Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan NV (NASDAQ:MYL).

Institutional Ownership by Quarter for Mylan (NASDAQ:MYL)

Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply